Role for Daple in non‐canonical Wnt signaling during gastric cancer invasion and metastasis

In gastric cancer, the non‐canonical Wnt signaling pathway is activated by Wnt5a, which has a critical role in disease outcome. Previous studies have shown that Wnt5a mediates the expression of the extracellular matrix protein laminin γ2 through Rac and JNK activation to promote gastric cancer progression. However, the mechanism of this regulatory pathway has not been completely addressed. The scaffold protein Dvl is a major component of the Wnt signaling pathway. Here, we show that Dvl‐associating protein with a high frequency of leucine residues (Daple) mediates Wnt5a‐induced laminin γ2 expression. Immunohistochemical analysis showed marked expression of Daple in advanced clinical stages of gastric cancer, where it highly correlated with Wnt5a/b and laminin γ2 expression, the depth of wall invasion, and the frequency of lymph node metastasis. In cultured cancer cells, Daple depletion led to the suppression of Wnt5a‐induced Rac and JNK activation, laminin γ2 expression, and cell migration and invasion. Accordingly, Daple depletion also suppressed liver metastasis in a mouse xenograft model of gastric cancer. These results suggest that the non‐canonical Wnt signaling pathway contributes to gastric cancer progression at least in part via Daple, which provides a new therapeutic opportunity for the treatment of the disease.

[1]  K. Willert,et al.  Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling , 2015, eLife.

[2]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[3]  W. Yang,et al.  Targeted therapy for gastric cancer: molecular pathways and ongoing investigations. , 2014, Biochimica et biophysica acta.

[4]  S. Tsui,et al.  A novel missense mutation in CCDC88C activates the JNK pathway and causes a dominant form of spinocerebellar ataxia , 2014, Journal of Medical Genetics.

[5]  R. Moon,et al.  WNT signalling pathways as therapeutic targets in cancer , 2012, Nature Reviews Cancer.

[6]  Khay Guan Yeoh,et al.  A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets , 2012, Gut.

[7]  Raymond K. Auerbach,et al.  Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation , 2012, Cell.

[8]  A. Kikuchi,et al.  Wnt5a: its signalling, functions and implication in diseases , 2012, Acta physiologica.

[9]  Y. Murakumo,et al.  The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility , 2012, Nature Communications.

[10]  H. Ohdan,et al.  An Anti-Wnt5a Antibody Suppresses Metastasis of Gastric Cancer Cells In Vivo by Inhibiting Receptor-Mediated Endocytosis , 2011, Molecular Cancer Therapeutics.

[11]  J. Ajani,et al.  Gastric cancer--an enigmatic and heterogeneous disease. , 2010, JAMA.

[12]  Y. Murakumo,et al.  Roles of Disrupted-In-Schizophrenia 1-Interacting Protein Girdin in Postnatal Development of the Dentate Gyrus , 2009, Neuron.

[13]  H. Ohdan,et al.  Laminin γ2 Mediates Wnt5a-Induced Invasion of Gastric Cancer Cells , 2009 .

[14]  M. Bouchard,et al.  Gata3 Acts Downstream of β-Catenin Signaling to Prevent Ectopic Metanephric Kidney Induction , 2008, PLoS genetics.

[15]  M. Katoh,et al.  Dysregulation of stem cell signaling network due to germline mutation, SNP, helicobacter pylori infection, epigenetic change, and genetic alteration in gastric cancer , 2007, Cancer biology & therapy.

[16]  P. Polakis.  The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.

[17]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[18]  T. Asahara,et al.  Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. , 2006, Cancer research.

[19]  K. Miyazaki.  Laminin‐5 (laminin‐332): Unique biological activity and role in tumor growth and invasion , 2006, Cancer science.

[20]  A. Fukui,et al.  Novel Daple-like protein positively regulates both the Wnt/β-catenin pathway and the Wnt/JNK pathway in Xenopus , 2005, Mechanisms of Development.

[21]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[22]  S. Kitano,et al.  Re‐evaluation of mucin phenotypes of gastric minute well‐differentiated‐type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M‐GGMC, MUC2 and CD10 stains , 2004, Pathology international.

[23]  T. Asahara,et al.  Identification and characterization of a novel Dvl‐binding protein that suppresses Wnt signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[24]  T. Tsukamoto,et al.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis , 2003, Journal of Cancer Research and Clinical Oncology.

[25]  Jeffrey D. Axelrod,et al.  A Second Canon , 2003 .

[26]  Hans Clevers,et al.  Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.

[27]  Akira Kikuchi,et al.  Tumor formation by genetic mutations in the components of the Wnt signaling pathway , 2003, Cancer science.

[28]  Xi He,et al.  Coactivation of Rac and Rho by Wnt/Frizzled signaling is required for vertebrate gastrulation. , 2003, Genes & development.

[29]  N. Iizuka,et al.  Expression of estrogen receptor-α and -β mRNAs in human gastric cancer , 2002 .

[30]  H. Lee,et al.  Altered expression and mutation of β‐catenin gene in gastric carcinomas and cell lines , 2001 .

[31]  Y. Nakanishi,et al.  Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers , 2000, Gastric Cancer.

[32]  Y. Nagashima,et al.  Overexpression of Laminin γ2 Chain Monomer in Invading Gastric Carcinoma Cells , 1999 .

[33]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[34]  K. Tryggvason,et al.  Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. , 1995, Cancer research.

[35]  Y. Okada,et al.  Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. , 1993, Cancer research.

[36]  Y Shimoyama,et al.  Expression of E- and P-cadherin in gastric carcinomas. , 1991, Cancer research.

[37]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[38]  Ph.D. Eiichi Tahara M.D.,et al.  Molecular biology of gastric cancer , 2004, World Journal of Surgery.

[39]  Randall T Moon,et al.  A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. , 2003, Developmental cell.